SOLID FORMULATION

The invention relates to pharmaceutical formulations comprising an active pharmaceutical ingredient; and one of or a combination of methacrylic acid copolymer, or a cellulose derivative wherein the active pharmaceutical ingredient is a dengue viral replication inhibitor. Solid dosage forms comprisin...

Full description

Saved in:
Bibliographic Details
Main Authors Andersen, Sune Klint, Kimpe, Kristof Leonard, Somers, Ivan Henri M, Ravelingien, Matthieu Jean M, Zhu, Donghua
Format Patent
LanguageEnglish
Published 04.01.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to pharmaceutical formulations comprising an active pharmaceutical ingredient; and one of or a combination of methacrylic acid copolymer, or a cellulose derivative wherein the active pharmaceutical ingredient is a dengue viral replication inhibitor. Solid dosage forms comprising said pharmaceutical formulations, processes for preparing these and their use in methods of prevention and/or treatment and/or inhibition of viral replication are also described.
Bibliography:Application Number: US202118035279